Borac Cacak Triumph in Six-Goal Thriller Against Kabel Novi Sad

In a high-scoring Serbian Prva Liga spectacle, Borac Cacak emerged victorious with a 4-2 away win over Kabel Novi Sad on April 22, 2026. The match was an entertaining affair with plenty of attacking action, as Borac's clinical finishing ultimately overpowered a resilient Kabel side that fought until the final whistle.

Match Report: An End-to-End Encounter

From the outset, the game promised goals, with both teams showing attacking intent. Kabel Novi Sad, spurred on by their home fans, started brightly, but it was Borac Cacak who demonstrated ruthless efficiency in front of goal. They built a commanding lead, showcasing a potent attack that consistently found ways to breach the Kabel defense.

Goal-First Half Sets the Tone

Borac Cacak seized control of the match in the first half, scoring multiple times to put Kabel Novi Sad on the back foot. Their movement and combination play were too much for the home defense to handle. Kabel managed to pull a goal back before the interval, offering a glimmer of hope and setting the stage for a dramatic second half.

Second Half Drama and Sealing the Win

Kabel Novi Sad came out with renewed vigor after the break, scoring again to narrow the deficit and put real pressure on the visitors. However, just as a comeback seemed possible, Borac Cacak restored their two-goal advantage with a well-worked goal. They put the result beyond doubt with a late fourth, capitalizing on Kabel's commitment to attack to seal a memorable 4-2 victory.

Attacking Stars and League Implications

Borac Cacak's forward line and attacking midfielders were in sensational form, involved in most of the team's dangerous moves. This victory, achieved away from home, is a significant boost for their league campaign, showcasing their offensive firepower. For Kabel Novi Sad, the defensive frailties exposed in this match will be a major concern, despite the positive spirit shown in their fightback. The six-goal thriller will be remembered for Borac's clinical edge.